Pediatric Hypertension Completed Phase 3 Trials for Azilsartan medoxomil (DB08822)

IndicationStatusPhase
DBCOND0033676 (Pediatric Hypertension)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02791438A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With HypertensionTreatment
NCT02451150A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With HypertensionTreatment